Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Vivus withdraws Alibra NDA

Oct. 23, 2000

New series of PDE5 inhibitors and their use described by Sanofi-Synthelabo

Oct. 19, 2000

Abbott researchers design novel water-soluble K+ channel openers

Oct. 17, 2000

Novel 5-HT reuptake inhibitors specifically claimed for use in premature ejaculation

Oct. 16, 2000

U.K. authorities clear new ED treatment for launch

Oct. 16, 2000

NitroMed describes improved methods of treating sexual dysfunction

Oct. 13, 2000

Mechanism of potential new treatment for erectile dysfunction elucidated

Oct. 13, 2000

Role for rho kinase inhibitors in the management of ED

Oct. 11, 2000

Synaptic's alpha1-adrenoceptors and BPH patents licensed to R.W. Johnson

Oct. 11, 2000

Central 5-HT2C receptor agonist exerts proerectile activity in two animal species

Oct. 9, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...